In 2006, Min Zhao and Colin McCaig, working between the University of California, Davis and the University of Aberdeen, published a paper in Nature showing something that sounds almost too clean to be biology: skin cells placed in an electric field of about the same strength found naturally at a wound site will get up and migrate, in a straight line, toward the negative pole. Turn the field around, and the cells turn around with it. The paper identified the molecular steering wheel, an enzyme called phosphatidylinositol-3-OH kinase gamma working opposite a tumor suppressor called PTEN, and it confirmed something researchers had suspected since the 1970s without being able to fully prove: wounds generate their own electric fields, and those fields are not a side effect of injury. They are an instruction.
This matters because wound healing is not, fundamentally, a chemistry problem the way most of medicine treats it. Growth factors and cytokines tell cells to divide and to stop dividing. They don’t tell a cell which direction to walk. Something else has to supply that information, especially in the first hours after injury when a gap in the skin needs to close before infection sets in. The electric field at a wound edge turns out to be one of the fastest, most direct ways the body answers the question of direction. You can block every growth factor you want and the field is still there, still pointing cells toward the gap.
Your Skin Is Basically a Battery, and a Cut Opens the Circuit
The epidermis maintains a voltage across itself at all times, even when nothing is wrong. Ion pumps and channels in skin cells move sodium inward and chloride and potassium around in a lopsided way, so the outer layer of skin sits at a different electrical potential than the tissue underneath it, typically somewhere in the range of 30 to 60 millivolts, with the surface negative relative to the inside. Researchers call this the transepithelial potential, and physiologist Richard Borgens, who spent much of his career at Purdue University studying electric fields in injury and regeneration, popularized a simpler name for it: the skin battery.
A battery only does something interesting when you connect its terminals. An intact layer of skin is an insulator, so the voltage just sits there, doing nothing visible. Cut the skin, and you’ve shorted the circuit. Current that was previously trapped now has a path to flow, out through the wound and back in through the surrounding tissue, driven by the same ion pumps that were maintaining the voltage in the first place. That current flowing through the salty, conductive fluid of the wound bed creates a lateral electric field across the exposed tissue, strongest right at the wound margin and weakening with distance. Measurements taken with vibrating probe electrodes, a technique Lionel Jaffe and Richard Nuccitelli helped develop in the late 1970s to detect these currents in living tissue without damaging it further, have put the field strength at wound edges somewhere around 100 to 200 millivolts per millimeter in mammalian skin, decaying over the first few millimeters away from the cut.
A wound is a short circuit, and the body reads the current as a compass heading.
That number, 100 to 200 millivolts per millimeter, is not arbitrary. It’s close to the field strength Zhao’s team used in the lab to make keratinocytes march in formation. The body isn’t applying some exotic signal cells have to be taught to interpret. It’s using the same voltage gradient that already exists as a byproduct of normal skin physiology, and cells appear to have evolved to treat that gradient as meaningful the moment it appears.
Cells Don’t Wander Toward a Cut, They Get Pushed There
The directional response to an electric field has a name, galvanotaxis, sometimes called electrotaxis, and it shows up across an unusually wide range of cell types: keratinocytes, fibroblasts, corneal epithelial cells, even neutrophils and some immune cells involved in cleaning up a wound site. What Zhao and McCaig’s 2006 paper did was connect the behavior to a specific internal mechanism rather than leaving it as an unexplained correlation. PI3K gamma accumulates at the leading edge of a cell facing the cathode, the negative pole, and helps build the actin machinery that extends the cell forward. PTEN does roughly the opposite job at the trailing edge. Knock out the gene for PI3K gamma in mice, and keratinocytes lose a large part of their ability to orient in a field. Wounds in those mice close slower.
That last detail is the one that moves this from a neat cell-culture trick to something with actual medical stakes. The mice with impaired electric-field sensing didn’t just have cells that behaved oddly in a dish, they had slower-healing wounds in a living animal. The field isn’t a laboratory curiosity sitting alongside the real healing machinery of growth factors and immune signaling. It’s doing real work, in parallel with that chemistry, nudging cells toward closure faster than chemical gradients alone would manage, because an electric field can be sensed and responded to within minutes, while a diffusing concentration gradient of a growth factor takes much longer to establish across a wound bed.
Skin cells don’t drift toward a cut. Voltage tells them which way to walk.
Think about what that buys an organism. A deep scratch in the skin of a mouse, or a person, is an open door for bacteria. Chemical signaling is comparatively slow and diffuse. An electric field, by contrast, snaps on the instant the skin barrier breaks and the ion pumps start driving current through the new opening, and it points directly at the gap that needs filling, because the field is generated by the gap itself. It’s a self-correcting signal: the stronger and wider the wound, the larger the current, and as the wound closes and the circuit re-insulates itself, the field weakens and eventually disappears, right as the directional cue is no longer needed.
Where the Clean Science Runs Into Messy Wounds
Here’s the honest complication. The experiments that pin down galvanotaxis, the ones with cells in a chamber and two electrodes delivering a precisely controlled field, are a long way from a human leg with a diabetic ulcer. Chronic wounds, the kind that actually drive serious clinical outcomes like amputation, don’t fail to close because the electric field theory is wrong. They fail to close because the whole local environment is broken: poor blood flow starves the tissue of oxygen, high glucose impairs immune cell function, bacterial biofilms sit on the wound surface, and the skin’s own ion-pumping machinery, the thing generating the field in the first place, is often damaged in exactly the tissue that needs it most. You can’t recreate a laboratory field strength over tissue that has lost the capacity to generate or respond to one.
This is the gap between “electric fields guide wound healing” as a cell-biology fact, which is well established, and “applying an external electric field will reliably heal chronic wounds,” which has a much messier track record. Clinical trials of electrical stimulation therapy for pressure ulcers, venous ulcers, and diabetic foot ulcers go back decades, and the results are a mixed bag: some show meaningfully faster closure rates compared to standard dressing care, others show marginal or statistically weak effects, and the field strengths, waveforms, and electrode placements used across studies vary enough that comparing them cleanly is difficult. The Centers for Medicare and Medicaid Services decided the evidence was strong enough by 2004 to cover electrical stimulation as a therapy for chronic Stage III and Stage IV pressure ulcers, arterial ulcers, venous ulcers, and diabetic ulcers, but only after 30 days of standard wound care had already failed to produce improvement. That’s a narrow, conditional endorsement, not a blanket one.
Turning a Bench Finding Into a Dressing You Can Buy
A handful of companies have tried to engineer products around the injury-current principle rather than around generic electrical stimulation. Procellera, a wound dressing developed by Vomaris and marketed in the United States, embeds a microscopic grid of silver and zinc that generates a weak electric field on its own once it contacts wound fluid, essentially a disposable battery built into the bandage, intended to supplement or mimic the current the skin would have generated if it weren’t injured. Other approaches use external power supplies to deliver high-voltage pulsed current or direct current through electrodes placed near the wound margin, closer in spirit to the original Zhao and McCaig lab setup. None of these have become standard first-line care the way, say, antibiotic ointment or compression therapy has. They occupy a second-line role, options doctors reach for after conventional treatment stalls.
| Approach | How it works | Clinical status |
|---|---|---|
| High-voltage pulsed current (HVPC) | External device delivers pulsed current through surface electrodes near wound margin | Medicare-covered for chronic ulcers after 30 days of failed standard care |
| Direct current (DC) stimulation | Continuous low-level current mimicking natural injury current polarity | Used in research and some specialty wound clinics, mixed trial outcomes |
| Self-powered microcell dressing (Procellera) | Silver and zinc grid generates its own field on contact with wound fluid | FDA-cleared wound dressing, marketed as adjunct therapy |
The limitation worth stating plainly: none of these devices can replicate the precision of the biological original. The natural injury current is generated locally, by the exact cells at the exact wound margin, shaped continuously by the tissue’s own feedback as the gap narrows. An external electrode delivers a field that’s cruder, less adaptive, and has to be guessed at in terms of strength and duration. It’s the difference between a thermostat built into a room and someone outside occasionally checking the temperature and adjusting a space heater. Both can warm the room. Only one is actually part of the system.
What This Says About How the Body Solves Problems
The deeper reason this research keeps surfacing in bioelectricity circles, beyond wound care specifically, is that it’s one of the cleanest demonstrations that cells use voltage as information independent of any chemical messenger. Michael Levin’s lab at Tufts has spent years extending this idea into limb regeneration and developmental patterning, arguing that bioelectric gradients help tell cells not just which way to move but what to become. Wound healing is the simplest, most observable version of that broader claim, because you can watch it happen in real time under a microscope, measure the field with a probe, and knock out the exact gene that lets a cell read it.
The injury current doesn’t replace the chemistry of healing. Growth factors still have to arrive, immune cells still have to clear debris, new blood vessels still have to form. But the electric field appears to be the fastest signal on the scene, present within minutes of injury and gone within days of closure, doing the one job chemistry is slow at: telling a cell, right now, which direction is the wound.
The open question isn’t whether the field exists or whether cells respond to it. Both are settled. The open question is whether medicine can learn to generate a wound’s own current with enough fidelity to matter in tissue that has already lost the ability to generate it itself, in a diabetic foot, in an elderly patient’s thinning skin, in the places where healing actually fails. Until a device can do that as precisely as the skin does it by accident, the injury current will remain one of the best-documented and least fully harnessed signals in the body.
Credit: Dan Meyers on Unsplash